资讯

JD Supra11 分钟
FDA Approves Biocon Biologics’ Bevacizumab Biosimilar
Biocon Biologics Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNE™ (bevacizumab-nwgd), a ...
Labmate Online51 分钟
Blocking enzyme could lead to improved treatment pathway in resistant form of melanoma
HPGDS enzyme plays key role in resistance of immunotherapy in various cancers  Up to 65% of patients with melanoma do not ...
The Institute of Cancer Research, London34 分钟
Opportunities for postdoctoral clinical fellows at the ICR
CRIS Cancer Foundation and the ICR are offering 2-3 year fellowships to support the development of outstanding early ...